HOME >> BIOLOGY >> NEWS
How to avoid severe climate change discussed at CO2 conference

Stanford, CA. The kind of devastation seen on the Gulf Coast from Hurricane Katrina may be a small taste of what is to come if emissions of the greenhouse gas carbon dioxide (CO2 ) are not diminished soon, warns Dr. Ken Caldeira of the Carnegie Institution's Department of Global Ecology in his opening remarks at the 7th International Carbon Dioxide Conference in Boulder, Colorado, September 26, 2005.

If current trends continue, some 5 trillion tons of carbon is expected to be spewed into the atmosphere over the next three centuries from human fossil-fuel burning. It will have serious consequences by warming the planet on average between 7 and 20 degrees Fahrenheit and turning the oceans acidic.

"These global changes would happen so fast they would overwhelm most natural processes and have devastating effects on plant and animal life on land and in the oceans. What we do this decade and the rest of this century will dramatically affect what happens to our planet for thousands of years to come," Caldeira cautions.

"Although centuries seem like a long time, they aren't when you look at how long it takes organisms to adapt to new conditions. What if people a few centuries ago had knowingly damaged our long-term climate and ocean chemistry for their short-term gain; what would we think of them?" he poses.

With stronger storms like Hurricane Katrina, the causes and effects of global climate change are gaining more public attention. The National Oceanic and Atmospheric Administration (NOAA) is hosting the 7th International Carbon Dioxide Conference in Boulder, Colorado, beginning September 26.

Experts from all over the world convene to evaluate methods used to study the CO2 cycle, describe research results, and discuss effective responses to climate change.

Caldeira's talk follows the opening address given by the Bush administration's James Mahoney, director of the U. S. Climate Change Science Pr
'"/>

Contact: Dr. Ken Caldeira
kcaldeira@globalecology.stanford.edu
650-704-7212
Carnegie Institution
21-Sep-2005


Page: 1 2 3

Related biology news :

1. Desertification: UN experts prescribe global policy overhaul to avoid looming mass migrations
2. The eyes have it! How box jellyfish avoid banging into things
3. Winning by a neck -- Giraffes avoid competing with shorter browsers
4. Embryonic selection of sex avoids conceiving blind children
5. How to avoid a bat
6. Define precautionary principle to avoid clashes over biotechnology under World Trade rules
7. Elephants avoid costly mountaineering
8. How plants avoid feeling the burn
9. Heal thyself: Systems biology model reveals how cells avoid becoming cancerous
10. Female guppies risk their lives to avoid too much male attention
11. Altering genetic blueprint of receptors in brain could help stroke victims avoid brain damage

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: How avoid severe climate change discussed conference

(Date:5/14/2015)... , May 14, 2015 Research and Markets ... of the "Fingerprint Sensors Market in Smart Mobile ... This report believes that 2014 was a watershed year ... Apple,s introduction of ,Apple Pay,. Apple gave fingerprint sensors ... mobile payment service. Fingerprint sensors are a must-have feature ...
(Date:5/11/2015)... DAYTON, Ohio , May 11, 2015  Through a ... Ohio had a strong showing at AUVSI,s ... . These representatives of Ohio,s UAS ... domestic and abroad from all points along the UAS ecosystem. ... Dayton Development Coalition,s (DDC) Vice President for Aerospace Rich ...
(Date:5/8/2015)... May 8, 2015 Synaptics Inc. (NASDAQ: SYNA ... that members of the executive management team will present at ... Technology, Media and Telecom Conference Date: May 18, 2015 ... Boston, MA Cowen and Company ... 2:45pm ET Location: The New York Palace Hotel, ...
Breaking Biology News(10 mins):Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2Synaptics to Present at Upcoming Investor Conferences 2
(Date:5/21/2015)... 2015 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the ... develops and commercializes proprietary technologies and products for advanced ... for the second fiscal quarter ended March 31, 2015. ... to advance business with our existing customers and to ... and CEO of SQI. "The delivery of a fully ...
(Date:5/21/2015)... San Francisco, CA (PRWEB) May 21, 2015 ... microbiome sequencing, has announced a partnership with PicnicHealth, ... records for patients. Participants diagnosed with Inflammatory Bowel ... as well as a complementary uBiome research kit. ... Summer 2014. , For more ...
(Date:5/21/2015)... LOS ANGELES , May 21, 2015 /PRNewswire/ ... research and development company specializing in oncology, today ... 2 clinical trial with aldoxorubicin for the treatment ... of brain cancer.  The open-label, multisite trial is ... of aldoxorubicin in patients whose tumors have progressed ...
(Date:5/21/2015)... 2015 Tunnell Consulting, Inc. ... as senior statistician and Principal, a position to which ... the management and analysis of complex and large data ... , “We’re delighted to have Julia join the Tunnell ... said Dr. Philippe Cini, Group Vice President and leader ...
Breaking Biology Technology:SQI Diagnostics Reports Second Quarter Financial Results 2SQI Diagnostics Reports Second Quarter Financial Results 3SQI Diagnostics Reports Second Quarter Financial Results 4SQI Diagnostics Reports Second Quarter Financial Results 5SQI Diagnostics Reports Second Quarter Financial Results 6SQI Diagnostics Reports Second Quarter Financial Results 7SQI Diagnostics Reports Second Quarter Financial Results 8uBiome Partners with PicnicHealth 2uBiome Partners with PicnicHealth 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Julia O’Neill Joins Tunnell Consulting’s Operational and Process Improvement Practice 2
Cached News: